Terms: = Lymphoma AND uPA
45 results:
1. Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.
Bønløkke ST; Fenger-Eriksen C; Ommen HB; Hvas AM
Blood Adv; 2023 Nov; 7(22):7056-7066. PubMed ID: 37756519
[TBL] [Abstract] [Full Text] [Related]
2. The Relationship Between Thrombo-Inflammatory Biomarkers and Cellular Indices of Inflammation in lymphoma Patients.
Jaradeh M; Baig N; Bontekoe E; Mitrovic M; Antic D; Hoppensteadt D; Kantarcioglu B; Fareed J
Clin Appl Thromb Hemost; 2021; 27():10760296211050358. PubMed ID: 34713728
[TBL] [Abstract] [Full Text] [Related]
3. Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer.
Chiang CH; Yeh CY; Chung JG; Chiang IT; Hsu FT
Anticancer Res; 2019 Jul; 39(7):3641-3649. PubMed ID: 31262890
[TBL] [Abstract] [Full Text] [Related]
4. Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation.
Courtoy GE; Donnez J; Marbaix E; Barreira M; Luyckx M; Dolmans MM
Gynecol Obstet Invest; 2018; 83(5):443-454. PubMed ID: 29227976
[TBL] [Abstract] [Full Text] [Related]
5. Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator.
Schrötzlmair F; Kopitz C; Halbgewachs B; Lu F; Algül H; Brünner N; Gänsbacher B; Krüger A
J Cell Mol Med; 2010 Dec; 14(12):2760-70. PubMed ID: 19863693
[TBL] [Abstract] [Full Text] [Related]
6. Expression of the urokinase plasminogen activator receptor (upaR) and its ligand (upa) in brain tissues of human immunodeficiency virus patients with opportunistic cerebral diseases.
Nebuloni M; Cinque P; Sidenius N; Ferri A; Lauri E; Omodeo-Zorini E; Zerbi P; Vago L
J Neurovirol; 2009 Jan; 15(1):99-107. PubMed ID: 19115132
[TBL] [Abstract] [Full Text] [Related]
7. Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1.
Stebel A; Brachetti C; Kunkel M; Schmidt M; Fritz G
Oncol Rep; 2009 Jan; 21(1):217-22. PubMed ID: 19082465
[TBL] [Abstract] [Full Text] [Related]
8. Amurubicinol-induced eotaxin-3 expression in human NCI-H69 small cell lung carcinoma cells.
Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Tanimoto M
Oncol Rep; 2006 Mar; 15(3):571-6. PubMed ID: 16465414
[TBL] [Abstract] [Full Text] [Related]
9. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Reijneveld JC; Brandsma D; Boogerd W; Bonfrer JG; Kalmijn S; Voest EE; Geurts-Moespot A; Visser MC; Taphoorn MJ
Neurology; 2005 Oct; 65(7):1120-2. PubMed ID: 16217072
[TBL] [Abstract] [Full Text] [Related]
10. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced upa expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
[TBL] [Abstract] [Full Text] [Related]
11. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?
Suh J; Rabson AB
J Cell Biochem; 2004 Jan; 91(1):100-17. PubMed ID: 14689584
[TBL] [Abstract] [Full Text] [Related]
12. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases.
Wolf K; Müller R; Borgmann S; Bröcker EB; Friedl P
Blood; 2003 Nov; 102(9):3262-9. PubMed ID: 12855577
[TBL] [Abstract] [Full Text] [Related]
13. Camptothecin induces urokinase-type plasminogen activator gene-expression in human RC-K8 malignant lymphoma and H69 small cell lung cancer cells.
Shibakura M; Niiya K; Kiguchi T; Nakata Y; Tanimoto M
Acta Med Okayama; 2002 Oct; 56(5):223-7. PubMed ID: 12530505
[TBL] [Abstract] [Full Text] [Related]
14. The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells.
Ramage JG; Vallera DA; Black JH; Aplan PD; Kees UR; Frankel AE
Leuk Res; 2003 Jan; 27(1):79-84. PubMed ID: 12479856
[TBL] [Abstract] [Full Text] [Related]
15. Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells.
Kiguchi T; Niiya K; Shibakura M; Miyazono T; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Nakata Y; Harada M
Int J Cancer; 2001 Sep; 93(6):792-7. PubMed ID: 11519039
[TBL] [Abstract] [Full Text] [Related]
16. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A
Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421
[TBL] [Abstract] [Full Text] [Related]
17. Myeloid leukaemic cells can lyse fibrin directly.
Robbie L; Berry S; Moir E; Booth NA; Culligan D; Tighe J; Watson H; King D; Bennett B
Br J Haematol; 2000 Nov; 111(2):524-9. PubMed ID: 11122094
[TBL] [Abstract] [Full Text] [Related]
18. The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity.
Dear AE; Medcalf RL
Biochim Biophys Acta; 2000 Jun; 1492(1):15-22. PubMed ID: 11004477
[TBL] [Abstract] [Full Text] [Related]
19. Philadelphia positive acute lymphoblastic leukaemia (ALL): clinico-haematologic characteristics, molecular analyses and 3-year follow up--a single institution study.
Vellupillai M; Tan LT; Lau LC; Fook-Chong SM; Lim LC
Ann Acad Med Singap; 2000 Mar; 29(2):159-63. PubMed ID: 10895331
[TBL] [Abstract] [Full Text] [Related]
20. Plasminogen activation in human acute leukaemias.
Scherrer A; Wohlwend A; Kruithof EK; Vassalli JD; Sappino AP
Br J Haematol; 1999 Jun; 105(4):920-7. PubMed ID: 10554801
[TBL] [Abstract] [Full Text] [Related]
[Next]
